IRAK inhibitor 3

CAS No. 1012343-93-9

IRAK inhibitor 3( —— )

Catalog No. M26259 CAS No. 1012343-93-9

IRAK inhibitor 3 is an interleukin-1 (IL-1) receptor-associated kinase (IRAK) modulator.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 250 Get Quote
2MG 136 Get Quote
5MG 227 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    IRAK inhibitor 3
  • Note
    Research use only, not for human use.
  • Brief Description
    IRAK inhibitor 3 is an interleukin-1 (IL-1) receptor-associated kinase (IRAK) modulator.
  • Description
    IRAK inhibitor 3 is an interleukin-1 (IL-1) receptor-associated kinase (IRAK) modulator.(In Vitro):IRAK inhibitor 3 can be used for treating an inflammatory condition, cell proliferative disorder, immune disorder.is an IRAK modulator.
  • In Vitro
    IRAK inhibitor 3 is an IRAK modulator, which can be used for treating an inflammatory condition, cell proliferative disorder, immune disorder.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    IRAK
  • Recptor
    SHP-2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1012343-93-9
  • Formula Weight
    439.49
  • Molecular Formula
    C21H21N5O4S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 13 mg/mL (29.58 mM)
  • SMILES
    COc1ccc(cc1OC)-c1cnc2ccc(NCc3ccc(cc3)S(N)(=O)=O)nn12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Nichols RJ, et al. RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancers. Nat Cell Biol. 2018 Sep;20(9):1064-1073.
molnova catalog
related products
  • Edecesertib

    Edecesertib (GS-5718) is a selective, orally active IRAK-4 inhibitor with anti-inflammatory properties, applicable for the study of rheumatoid arthritis (RA) and lupus erythematosus (LE).

  • IRAK-4 protein kinas...

    IRAK-4 protein kinase inhibitor 2 is a potent interleukin-1 receptor-associated kinase-4 (IRAK-4) inhibitor(IC50 = 4 μM).

  • CA-4948

    CA-4948 (AU-4948) is a novel potent, selective, orally bioavailable IRAK4 inhibitor.